GSK Says Patient Treated With Arzerra Had Fatal Reaction
2014-08-06 12:30:17.828 GMT
By Jurjen van de Pol
Aug. 6 (Bloomberg) -- GlaxoSmithKline says a severe
infusion reaction resulting in death was reported in a patient
with chronic lymphocytic leukemia who was given Arzerra.
Link to Statement:{NSN N9VWQH3S3GU8 <GO>}
Link to Company News:{GSK LN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Jurjen van de Pol in Frankfurt at +49-69-9204-1104 or
jvandepol@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
2014-08-06 12:30:17.828 GMT
By Jurjen van de Pol
Aug. 6 (Bloomberg) -- GlaxoSmithKline says a severe
infusion reaction resulting in death was reported in a patient
with chronic lymphocytic leukemia who was given Arzerra.
Link to Statement:{NSN N9VWQH3S3GU8 <GO>}
Link to Company News:{GSK LN <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Jurjen van de Pol in Frankfurt at +49-69-9204-1104 or
jvandepol@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net